| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2023 | BMRA Biomerica Inc | Barbieri Allen | Executive Vice Chairman | Buy | 1,538 | $2.94 | $4,521.72 | +1.5% | -55.2% | -68.8% | |
| Jan 27, 2023 | OM Outset Medical, Inc. | Porter Stacey L.89 | Chief People Officer | Sell | 2,295 | $27.92 | $64,076.40 | -3.4% | -38.7% | -87.6% | |
| Jan 27, 2023 | OM Outset Medical, Inc. | Vazquez Martin84 | Chief Operating Officer | Sell | 4,674 | $27.92 | $130,498.08 | -4.3% | -38.7% | -87.6% | |
| Jan 27, 2023 | PEN Penumbra Inc | Kassing Don W.49 | Director | Sell | 693 | $243.54 | $168,773.22 | -31.0% | +13.1% | +0.8% | |
| Jan 27, 2023 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 6,281 | $27.92 | $175,365.52 | -1.5% | -38.7% | -87.6% | |
| Jan 27, 2023 | WRBY Warby Parker Inc. | Durable Capital Partners LP56 | 10% Owner | Sell | 38,309 | $17.05 | $653,124.08 | -0.1% | -37.0% | -22.5% | |
| Jan 27, 2023 | AXGN Axogen, Inc. | Mariani Peter J65 | EVP &Chief Financial Officer | Sell | 62,818 | $10.10 | $634,252.47 | -33.2% | -10.9% | -6.7% | |
| Jan 26, 2023 | BMRA Biomerica Inc | Coste Catherine | Director, Audit Committee Chairperson | Buy | 2,190 | $2.96 | $6,482.40 | +5.3% | -58.7% | -69.9% | |
| Jan 26, 2023 | INCY Incyte Corp | Iyengar Vijay K62 | EVP, Gmapps | Sell | 7,000 | $85.00 | $595,000.00 | -14.0% | -14.5% | -29.5% | |
| Jan 26, 2023 | INCY Incyte Corp | Dhanak Dashyant75 | EVP &Chief Scientific Officer | Sell | 2,419 | $85.00 | $205,615.00 | -4.3% | -14.5% | -29.5% | |
| Jan 25, 2023 | BMRA Biomerica Inc | Irani Zackary S. | Chief Executive Officer | Buy | 1,800 | $2.85 | $5,130.00 | +0.2% | -55.1% | -68.5% | |
| Jan 25, 2023 | TMCI Treace Medical Concepts, Inc. | Bays F Barry80 | Director | Sell | 53,643 | $25.70 | $1,378,843.74 | -1.3% | +0.9% | -49.7% | |
| Jan 24, 2023 | CTKB Cytek Biosciences, Inc. | Jeanmonod Patrik77 | Chief Financial Officer | Sell | 3,500 | $11.05 | $38,675.00 | -4.4% | -9.7% | -22.8% | |
| Jan 24, 2023 | WRBY Warby Parker Inc. | Durable Capital Partners LP56 | 10% Owner | Sell | 13,968 | $17.00 | $237,456.00 | -0.1% | -34.7% | -22.5% | |
| Jan 24, 2023 | BMRA Biomerica Inc | Irani Zackary S. | Chief Executive Officer | Buy | 2,000 | $2.81 | $5,620.00 | +0.2% | -52.1% | -66.1% | |
| Jan 24, 2023 | ATEC Alphatec Holdings, Inc. | Miles Patrick53 | CEO | Sell | 180,000 | $13.16 | $2,368,200.00 | -1.1% | +19.4% | +22.6% | |
| Jan 23, 2023 | BLFS Biolife Solutions Inc | Schulz Marcus71 | Chief Revenue Officer | Sell | 1,000 | $25.02 | $25,020.00 | -2.3% | -23.2% | -30.7% | |
| Jan 23, 2023 | STIM Neuronetics, Inc. | MacAn William Andrew66 | SVP And General Counsel | Sell | 16,046 | $5.96 | $95,634.16 | -4.5% | -61.9% | -42.5% | |
| Jan 23, 2023 | PEN Penumbra Inc | Bose Arani57 | Director | Sell | 20,000 | $250.25 | $5,005,000.00 | -4.3% | +15.0% | +0.9% | |
| Jan 23, 2023 | DXCM Dexcom Inc | Pacelli Steven Robert57 | EVP Managing Director Dexcom V | Sell | 412 | $107.86 | $44,438.32 | -0.3% | +16.4% | +19.5% | |
| Jan 23, 2023 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 3,142 | $65.07 | $204,449.94 | -70.7% | +30.2% | +28.6% | |
| Jan 23, 2023 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Sell | 12,362 | $65.42 | $808,664.32 | -1.5% | +30.2% | +28.6% | |
| Jan 23, 2023 | GEHC Ge Healthcare Technologies Inc. | Culp H Lawrence Jr | Director | Buy | 748 | $69.26 | $51,806.48 | +142.7% | +26.3% | +6.0% | |
| Jan 23, 2023 | HAE Haemonetics Corp | Llorens Josep59 | EVP, Global Manufacturing | Sell | 2,391 | $90.00 | $215,190.00 | -12.2% | -5.7% | -6.8% | |
| Jan 23, 2023 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 3,500 | $25.01 | $87,535.00 | -2.9% | -23.2% | -30.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.